Evidence map›Paper›PMID 29879549›Full record

ArticleRedox biology2018

The role of autophagy in survival response induced by 27-hydroxycholesterol in human promonocytic cells.

Beyza Vurusaner, Simona Gargiulo, Gabriella Testa, Paola Gamba, Gabriella Leonarduzzi, Giuseppe Poli, Huveyda Basaga

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. 27-Hydroxycholesterol in cancer development and drug resistance.Journal of enzyme inhibition and medicinal chemistry · 2025
    Review
  2. Autophagy: a double-edged sword in ischemia-reperfusion injury.Cellular & molecular biology letters · 2025
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Oxysterols in Vascular Cells and Role in Atherosclerosis.Advances in experimental medicine and biology · 2024
    Article
  9. Article
  10. Defects of Nutrient Signaling and Autophagy in Neurodegeneration.Frontiers in cell and developmental biology · 2022
    Review
  11. Article
  12. Molecular medicine reports · 2021
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Beyza VurusanerBiological Sciences and Bioengineering Program, Faculty of Engineering and Natural Sciences, Sabanci University, Orhanli-Tuzla, 34956 Istanbul, Turkey. Electronic address: beyzav@sabanciuniv.edu.
Simona GargiuloDepartment of Clinical and Biological Sciences, University of Torino, Torino, Italy. Electronic address: simona.gargiulo@unito.it.
Gabriella TestaDepartment of Clinical and Biological Sciences, University of Torino, Torino, Italy. Electronic address: gabriella.testa@unito.it.
Paola GambaDepartment of Clinical and Biological Sciences, University of Torino, Torino, Italy. Electronic address: paola.gamba@unito.it.
Gabriella LeonarduzziDepartment of Clinical and Biological Sciences, University of Torino, Torino, Italy. Electronic address: gabriella.leonarduzzi@unito.it.
Giuseppe PoliDepartment of Clinical and Biological Sciences, University of Torino, Torino, Italy. Electronic address: giuseppe.poli@unito.it.
Huveyda BasagaBiological Sciences and Bioengineering Program, Faculty of Engineering and Natural Sciences, Sabanci University, Orhanli-Tuzla, 34956 Istanbul, Turkey. Electronic address: huveyda@sabanciuniv.edu.
University of Turin · ITSabancı Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autophagy has been shown to be stimulated in advanced atherosclerotic plaques by metabolic stress, inflammation and oxidized lipids. The lack of published studies addressing the potential stimulation of pro-survival autophagy by oxysterols, a family of cholesterol oxidation products, has prompted our study. Thus, the goal of the current study is to elucidate the molecular mechanism of the autophagy induced by 27-hydroxycholesterol (27-OH), that is one of the most abundant oxysterols in advanced atherosclerotic lesions, and to assess whether the pro-oxidant effect of the oxysterol is involved in the given response. Here we showed that 27-OH, in a low micromolar range, activates a pro-survival autophagic response in terms of increased LC3 II/LC3 I ratio and Beclin 1, that depends on the up-regulation of extracellular signal-regulated kinase (ERK) and phosphoinositide 3-kinase (PI3K)/Akt pathways as a potential result of an intracellular reactive oxygen species increase provoked by the oxysterol in human promonocytic U937 cells. Moreover, 27-OH induced autophagy is dependent on the relation between nuclear factor erythroid 2 p45-related factor 2 (Nrf2)-dependent antioxidant response and p62. The data obtained highlight the involvement of cholesterol oxidation products in the pathogenesis of oxidative stress related chronic diseases like atherosclerosis. Therefore, deeply understanding the complex mechanism and generating synthetic or natural molecules targeting this survival mechanism might be very promising tools in the prevention of such diseases.

Indexed as

AntioxidantsApoptosisAtherosclerosisAutophagyCell SurvivalCholesterolHumansHydroxycholesterolsMonocyte-Macrophage Precursor CellsNF-E2-Related Factor 2Oxidative StressReactive Oxygen SpeciesRNA-Binding Proteins27-hydroxycholesterolAntioxidantsCholesterolHydroxycholesterolsNFE2L2 protein, humanNF-E2-Related Factor 2P62 protein, humanReactive Oxygen SpeciesRNA-Binding Proteins27-hydroxycholesterolAutophagyOxysterolsROSSurvival signaling

Identifiers

PMID29879549
PMCPMC5986166
OpenAlexW2803927571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.